• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR Back to Search Results
Model Number OP-05D
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Date 09/14/2020
Event Type  Injury  
Manufacturer Narrative
The product of this event was not returned to the manufacturer and could not be analyzed.The lot number of the product was not reported, and we could not review the manufacturing and quality control records.The physician's commented that this event is non-serious and the causal relationship between this event and plasmaflo op-05d and/or cascadeflo ec-20w was suspicious because adverse event occurred during treatment.We considered that this event as "serious" because the blood pressure was decreased to 68 mmhg and administering medication was required for treatment.Also, we considered the causal relationship between the event and plasmaflo op-05d could not be denied because the patient experienced adverse event during the treatment and the physician commented as above.Hypotonia which is convertible term of hypotension is described in e.Precautions of ifu as "13 monitor the patient constantly during treatment with the plasmaflo¿ op-05w(a).In the event of any of the following during treatment, immediately ensure the safety of the patient and take appropriate measures in accordance with the directions of the responsible physician.Headache, nausea, vomiting, discomfort, chest pain, abdominal pain, hypotonia, hypertension, violent coughing, difficulty breathing, poor complexion, edema of eyelids, heart palpitation, dizziness, pyrexia, chill, causalgia, abnormal sweating, paresthesia, urticaria, muscle cramps, tinnitus, abnormal stimulation of the lachrymal glands, nasal blockage, or complaints of abnormal sensations of taste, smell, or itching, or any other adverse reaction or side effect observed in the patient." we will continue to monitor the occurrence of similar events carefully.
 
Event Description
This case occurred in (b)(6).We received this report from medical engineer who is the initial reporter of this incident.The adverse event of "blood pressure decreased" was occurred when the double filtration plasmapheresis (dfpp) treatment was performed for the purpose of antibody removal in patient with diabetic nephropathy who was planning to have an abo-incompatible kidney transplant.09:50 dfpp treatment was performed using the medical device of plasmaflo op-05d, which is used as plasma separator and is a similar product to plasmaflo op-05w(a) marketed in us, and cascadeflo ec-20w which separates substances in a certain molecular weight region from separated plasma and is marketed in (b)(6).Hemodialysis (hd) was also performed using another manufacturer's dialyzer during the treatment of dfpp.The patient's blood pressure at the start of treatment was 160/80 mmhg.10:15 the patient complained of chest pain.His lower limbs were elevated, dfpp and hd treatment were stopped, and etilefrine hydrochloride and oxygen were administered.10:18 hydroxyzine hydrochloride was administered.10:30 blood pressure was decreased to 68/41 mmhg and pulse was 50 to 60 per minute.Normal saline and methylprednisolone sodium succinate were administered.10:45 dfpp treatment was restarted.11:00 since the patient complained of chest pain and systolic blood pressure was 70 mmhg, dfpp treatment was discontinued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
oita works
2111-2 oaza sato
oita-shi, 870-0 396
JA   870-0396
Manufacturer Contact
naomi kagami
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0-006
JA   100-0006
MDR Report Key10668336
MDR Text Key211306036
Report Number8010002-2020-00100
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberOP-05D
Device Catalogue NumberN/A
Device Lot NumberN/A
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/14/2020
Initial Date FDA Received10/13/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
-
-